Market Analysis and Insights:
The global Breast-Conserving Surgery market size is projected to reach US$ 2529 million by 2028, from US$ 1533 million in 2021, at a CAGR of 7.19% during 2022-2028.
Fully considering the economic change by this health crisis, Lumpectomy Systems accounting for 46.44% of the Breast-Conserving Surgery global market in 2021, is projected to value US$ 1133 million by 2028, growing at a revised 6.6% CAGR between 2022 and 2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast-Conserving Surgery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast-Conserving Surgery market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast-Conserving Surgery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast-Conserving Surgery market.
Scope and Market Size:
Breast-Conserving Surgery market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast-Conserving Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
- Hologic
- BD
- Danaher
- Carl Zeiss Meditech
- Merit Medical
- Argon Medical Devices
- IceCure
- Endomagnetics
- SOMATEX Medical
- Ranfac
- STERYLAB
- SamanTree Medical
- Perimeter Medical Imaging AI
- Dilon Technologies
- XEOS Medical
Segment by Type
- Lumpectomy Systems
- Lumpectomy Surgical Tools
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
By Region
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe
- South America
- Brazil
- Rest of South America
TABLE OF CONTENTS
1 REPORT OVERVIEW
- 1.1 STUDY SCOPE
- 1.2 MARKET ANALYSIS BY TYPE
- 1.2.1 GLOBAL BREAST-CONSERVING SURGERY MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028
- 1.2.2 LUMPECTOMY SYSTEMS
- 1.2.3 LUMPECTOMY SURGICAL TOOLS
- 1.3 MARKET BY APPLICATION
- 1.3.1 GLOBAL BREAST-CONSERVING SURGERY MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028
- 1.3.2 HOSPITALS
- 1.3.3 AMBULATORY SURGICAL CENTERS
- 1.4 STUDY OBJECTIVES
- 1.5 YEARS CONSIDERED
- 1.6 NO. OF MEDICAL CENTERS AND PERFORMS BREAST SURGERIES, OPERATION ROOMS FOR BREAST CANCER
- 1.7 AMOUNT OF 1ST AND 2ST BREAST CONSERVING SURGERIES PER REGION 2021
2 GLOBAL GROWTH TRENDS
- 2.1 GLOBAL BREAST-CONSERVING SURGERY MARKET PERSPECTIVE (2017-2028)
- 2.2 BREAST-CONSERVING SURGERY GROWTH TRENDS BY REGION
- 2.2.1 BREAST-CONSERVING SURGERY MARKET SIZE BY REGION: 2017 VS 2021 VS 2028
- 2.2.2 BREAST-CONSERVING SURGERY HISTORIC MARKET SIZE BY REGION (2017-2022)
- 2.2.3 BREAST-CONSERVING SURGERY FORECASTED MARKET SIZE BY REGION (2023-2028)
- 2.3 BREAST-CONSERVING SURGERY MARKET DYNAMICS
- 2.3.1 BREAST-CONSERVING SURGERY INDUSTRY TRENDS
- 2.3.2 BREAST-CONSERVING SURGERY MARKET DRIVERS
- 2.3.3 BREAST-CONSERVING SURGERY MARKET CHALLENGES
- 2.3.4 BREAST-CONSERVING SURGERY MARKET RESTRAINTS
3 COMPETITION LANDSCAPE BY KEY PLAYERS
- 3.1 GLOBAL TOP BREAST-CONSERVING SURGERY PLAYERS BY REVENUE
- 3.1.1 GLOBAL TOP BREAST-CONSERVING SURGERY PLAYERS BY REVENUE (2017-2022)
- 3.1.2 GLOBAL BREAST-CONSERVING SURGERY REVENUE MARKET SHARE BY PLAYERS (2017-2022)
- 3.2 GLOBAL BREAST-CONSERVING SURGERY BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
- 3.3 PLAYERS COVERED: RANKING BY BREAST-CONSERVING SURGERY REVENUE
- 3.4 GLOBAL BREAST-CONSERVING SURGERY MARKET CONCENTRATION RATIO
- 3.4.1 GLOBAL BREAST-CONSERVING SURGERY MARKET CONCENTRATION RATIO (CR5 AND HHI)
- 3.4.2 GLOBAL TOP 10 AND TOP 5 COMPANIES BY BREAST-CONSERVING SURGERY REVENUE IN 2021
- 3.5 BREAST-CONSERVING SURGERY KEY PLAYERS HEAD OFFICE AND AREA SERVED
- 3.6 KEY PLAYERS BREAST-CONSERVING SURGERY PRODUCT SOLUTION AND SERVICE
- 3.7 FOUNDED DATE OF BREAST-CONSERVING SURGERY COMPANY
- 3.8 MERGERS & ACQUISITIONS, EXPANSION PLANS
4 BREAST-CONSERVING SURGERY BREAKDOWN DATA BY TYPE
- 4.1 GLOBAL BREAST-CONSERVING SURGERY HISTORIC MARKET SIZE BY TYPE (2017-2022)
- 4.2 GLOBAL BREAST-CONSERVING SURGERY FORECASTED MARKET SIZE BY TYPE (2023-2028)
5 BREAST-CONSERVING SURGERY BREAKDOWN DATA BY APPLICATION
- 5.1 GLOBAL BREAST-CONSERVING SURGERY HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
- 5.2 GLOBAL BREAST-CONSERVING SURGERY FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
6 NORTH AMERICA
- 6.1 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE (2017-2028)
- 6.2 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE
- 6.2.1 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2017-2022)
- 6.2.2 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2023-2028)
- 6.2.3 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SHARE BY TYPE (2017-2028)
- 6.3 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION
- 6.3.1 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2017-2022)
- 6.3.2 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2023-2028)
- 6.3.3 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SHARE BY APPLICATION (2017-2028)
- 6.4 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY
- 6.4.1 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY (2017-2022)
- 6.4.2 NORTH AMERICA BREAST-CONSERVING SURGERY MARKET SHARE BY COUNTRY (2023-2028)
- 6.4.3 UNITED STATES
- 6.4.4 CANADA
- 6.4.5 MEXICO
7 EUROPE
- 7.1 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE (2017-2028)
- 7.2 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE
- 7.2.1 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2017-2022)
- 7.2.2 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2023-2028)
- 7.2.3 EUROPE BREAST-CONSERVING SURGERY MARKET SHARE BY TYPE (2017-2028)
- 7.3 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION
- 7.3.1 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2017-2022)
- 7.3.2 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2023-2028)
- 7.3.3 EUROPE BREAST-CONSERVING SURGERY MARKET SHARE BY APPLICATION (2017-2028)
- 7.4 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY
- 7.4.1 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY (2017-2022)
- 7.4.2 EUROPE BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY (2023-2028)
- 7.4.3 GERMANY
- 7.4.4 FRANCE
- 7.4.5 U.K.
- 7.4.6 ITALY
- 7.4.7 RUSSIA
8 ASIA-PACIFIC
- 8.1 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE (2017-2028)
- 8.2 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE
- 8.2.1 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2017-2022)
- 8.2.2 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2023-2028)
- 8.2.3 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SHARE BY TYPE (2017-2028)
- 8.3 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION
- 8.3.1 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2017-2022)
- 8.3.2 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2023-2028)
- 8.3.3 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SHARE BY APPLICATION (2017-2028)
- 8.4 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY REGION
- 8.4.1 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY REGION (2017-2022)
- 8.4.2 ASIA-PACIFIC BREAST-CONSERVING SURGERY MARKET SIZE BY REGION (2023-2028)
- 8.4.3 CHINA
- 8.4.4 JAPAN
- 8.4.5 SOUTH KOREA
- 8.4.6 SOUTHEAST ASIA
- 8.4.7 INDIA
- 8.4.8 AUSTRALIA
9 SOUTH AMERICA
- 9.1 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE (2017-2028)
- 9.2 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE
- 9.2.1 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2017-2022)
- 9.2.2 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2023-2028)
- 9.2.3 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SHARE BY TYPE (2017-2028)
- 9.3 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION
- 9.3.1 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2017-2022)
- 9.3.2 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2023-2028)
- 9.3.3 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SHARE BY APPLICATION (2017-2028)
- 9.4 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY
- 9.4.1 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY (2017-2022)
- 9.4.2 SOUTH AMERICA BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY (2023-2028)
- 9.4.3 BRAZIL
10 MIDDLE EAST & AFRICA
- 10.1 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE (2017-2028)
- 10.2 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE
- 10.2.1 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2017-2022)
- 10.2.2 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY TYPE (2023-2028)
- 10.2.3 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SHARE BY TYPE (2017-2028)
- 10.3 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION
- 10.3.1 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2017-2022)
- 10.3.2 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY APPLICATION (2023-2028)
- 10.3.3 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SHARE BY APPLICATION (2017-2028)
- 10.4 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY
- 10.4.1 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY (2017-2022)
- 10.4.2 MIDDLE EAST & AFRICA BREAST-CONSERVING SURGERY MARKET SIZE BY COUNTRY (2023-2028)
- 10.4.3 MIDDLE EAST
- 10.4.4 AFRICA
11 KEY PLAYERS PROFILES
- 11.1 HOLOGIC
- 11.1.1 HOLOGIC COMPANY DETAILS
- 11.1.2 HOLOGIC BUSINESS OVERVIEW
- 11.1.3 HOLOGIC BREAST-CONSERVING SURGERY INTRODUCTION
- 11.1.4 HOLOGIC REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.1.5 HOLOGIC RECENT DEVELOPMENT
- 11.2 BD
- 11.2.1 BD COMPANY DETAILS
- 11.2.2 BD BUSINESS OVERVIEW
- 11.2.3 BD BREAST-CONSERVING SURGERY INTRODUCTION
- 11.2.4 BD REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.2.5 BD RECENT DEVELOPMENT
- 11.3 DANAHER
- 11.3.1 DANAHER COMPANY DETAILS
- 11.3.2 DANAHER BUSINESS OVERVIEW
- 11.3.3 DANAHER BREAST-CONSERVING SURGERY INTRODUCTION
- 11.3.4 DANAHER REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.3.5 DANAHER RECENT DEVELOPMENT
- 11.4 CARL ZEISS MEDITECH
- 11.4.1 CARL ZEISS MEDITECH COMPANY DETAILS
- 11.4.2 CARL ZEISS MEDITECH BUSINESS OVERVIEW
- 11.4.3 CARL ZEISS MEDITECH BREAST-CONSERVING SURGERY INTRODUCTION
- 11.4.4 CARL ZEISS MEDITECH REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.4.5 CARL ZEISS MEDITECH RECENT DEVELOPMENT
- 11.5 MERIT MEDICAL
- 11.5.1 MERIT MEDICAL COMPANY DETAILS
- 11.5.2 MERIT MEDICAL BUSINESS OVERVIEW
- 11.5.3 MERIT MEDICAL BREAST-CONSERVING SURGERY INTRODUCTION
- 11.5.4 MERIT MEDICAL REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.5.5 MERIT MEDICAL RECENT DEVELOPMENT
- 11.6 ARGON MEDICAL DEVICES
- 11.6.1 ARGON MEDICAL DEVICES COMPANY DETAILS
- 11.6.2 ARGON MEDICAL DEVICES BUSINESS OVERVIEW
- 11.6.3 ARGON MEDICAL DEVICES BREAST-CONSERVING SURGERY INTRODUCTION
- 11.6.4 ARGON MEDICAL DEVICES REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.6.5 ARGON MEDICAL DEVICES RECENT DEVELOPMENT
- 11.7 ICECURE
- 11.7.1 ICECURE COMPANY DETAILS
- 11.7.2 ICECURE BUSINESS OVERVIEW
- 11.7.3 ICECURE BREAST-CONSERVING SURGERY INTRODUCTION
- 11.7.4 ICECURE REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.7.5 ICECURE RECENT DEVELOPMENT
- 11.8 ENDOMAGNETICS
- 11.8.1 ENDOMAGNETICS COMPANY DETAILS
- 11.8.2 ENDOMAGNETICS BUSINESS OVERVIEW
- 11.8.3 ENDOMAGNETICS BREAST-CONSERVING SURGERY INTRODUCTION
- 11.8.4 ENDOMAGNETICS REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.8.5 ENDOMAGNETICS RECENT DEVELOPMENT
- 11.9 SOMATEX MEDICAL
- 11.9.1 SOMATEX MEDICAL COMPANY DETAILS
- 11.9.2 SOMATEX MEDICAL BUSINESS OVERVIEW
- 11.9.3 SOMATEX MEDICAL BREAST-CONSERVING SURGERY INTRODUCTION
- 11.9.4 SOMATEX MEDICAL REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.9.5 SOMATEX MEDICAL RECENT DEVELOPMENT
- 11.10 RANFAC
- 11.10.1 RANFAC COMPANY DETAILS
- 11.10.2 RANFAC BUSINESS OVERVIEW
- 11.10.3 RANFAC BREAST-CONSERVING SURGERY INTRODUCTION
- 11.10.4 RANFAC REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.10.5 RANFAC RECENT DEVELOPMENT
- 11.11 STERYLAB
- 11.11.1 STERYLAB COMPANY DETAILS
- 11.11.2 STERYLAB BUSINESS OVERVIEW
- 11.11.3 STERYLAB BREAST-CONSERVING SURGERY INTRODUCTION
- 11.11.4 STERYLAB REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.12 SAMANTREE MEDICAL
- 11.12.1 SAMANTREE MEDICAL COMPANY DETAILS
- 11.12.2 SAMANTREE MEDICAL BUSINESS OVERVIEW
- 11.12.3 SAMANTREE MEDICAL BREAST-CONSERVING SURGERY INTRODUCTION
- 11.12.4 SAMANTREE MEDICAL REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.12.5 SAMANTREE MEDICAL RECENT DEVELOPMENT
- 11.13 PERIMETER MEDICAL IMAGING AI
- 11.13.1 PERIMETER MEDICAL IMAGING AI COMPANY DETAILS
- 11.13.2 PERIMETER MEDICAL IMAGING AI BUSINESS OVERVIEW
- 11.13.3 PERIMETER MEDICAL IMAGING AI BREAST-CONSERVING SURGERY INTRODUCTION
- 11.13.4 PERIMETER MEDICAL IMAGING AI REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.13.5 PERIMETER MEDICAL IMAGING AI RECENT DEVELOPMENT
- 11.14 DILON TECHNOLOGIES
- 11.14.1 DILON TECHNOLOGIES COMPANY DETAILS
- 11.14.2 DILON TECHNOLOGIES BUSINESS OVERVIEW
- 11.14.3 DILON TECHNOLOGIES BREAST-CONSERVING SURGERY INTRODUCTION
- 11.14.4 DILON TECHNOLOGIES REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.14.5 DILON TECHNOLOGIES RECENT DEVELOPMENT
- 11.15 XEOS MEDICAL
- 11.15.1 XEOS MEDICAL COMPANY DETAILS
- 11.15.2 XEOS MEDICAL BUSINESS OVERVIEW
- 11.15.3 XEOS MEDICAL BREAST-CONSERVING SURGERY INTRODUCTION
- 11.15.4 XEOS MEDICAL REVENUE IN BREAST-CONSERVING SURGERY BUSINESS (2017-2022)
- 11.15.5 XEOS MEDICAL RECENT DEVELOPMENT
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
- 13.1 RESEARCH METHODOLOGY
- 13.1.1 METHODOLOGY/RESEARCH APPROACH
- 13.1.2 DATA SOURCE
- 13.2 DISCLAIMER
- 13.3 AUTHOR DETAILS